PFBT
LAB icon

Parkside Financial Bank & Trust’s Standard BioTools LAB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165 Hold
200
– – ﹤0.01% 2671
2026
Q1 		$184 Sell
200
-413
-67% -$500 ﹤0.01% 2645
2025
Q4 		$785 Buy
613
+413
+207% +$555 ﹤0.01% 2417
2025
Q3 		$260 Hold
200
– – ﹤0.01% 2643
2025
Q2 		$240 Hold
200
– – ﹤0.01% 2659
2025
Q1 		$216 Buy
+200
New +$281 ﹤0.01% 2668

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Parkside Financial Bank & Trust's LAB Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Standard BioTools (LAB) position steady in Q2 2026 at 200 shares worth $165. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Parkside Financial Bank & Trust first reported a position in LAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $785 in Q4 2025. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Parkside Financial Bank & Trust held 200 shares of Standard BioTools worth $165 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Standard BioTools share count unchanged in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2671 holding.
  • Parkside Financial Bank & Trust first reported a position in Standard BioTools in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's Standard BioTools position peaked at $785 in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.